Nucleic acids encoding antiviral proteins and peptides fused to effector proteins
US5962668A · kind A · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1997 |
| Grant date | Oct 5, 1999 |
| Priority date | — |
| Expiry date | Nov 13, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6817
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences encoding such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.